Canvas Wealth Advisors LLC lessened its position in Amazon.com, Inc. (NASDAQ:AMZN) by 0.6% during the 4th quarter, ...

More than 9,000 X users reported experiencing problems with Elon Musk's social media site on Monday as users were met with ...

In a report released today, Laura Chico from Wedbush maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price ...

As previously reported, Wedbush analyst Robert Driscoll downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down ...

It was almost an extraordinary scene in front of the White House. As Tesla shares have been tanking since the year began, President Donald Trump held remarks outside of the White House with the ...

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla ...

Musk pumped $270 million into Trump's campaign heading into the 2024 election, appeared on stage with him and cheered Trump's ...

Investing.com-- Analysts at Wedbush Securities have added Tesla Inc (NASDAQ:TSLA) to their "Best Ideas List", citing expectations for a major innovation cycle ahead. Wedbush maintained an ...

Elon Musk spent the weekend with President Donald Trump at Mar-a-Lago, getting a round-trip ride on Air Force One. While Musk ...

“The DOGE efforts has now intertwined Tesla into this brewing political firestorm,” an analyst note from Wedbush Securities said Tuesday. “If Musk continues to head down the DOGE path 110% ...

Wedbush has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Apogee Therapeutics’ current full-year earnings is ($3.09) per share.

Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives, Tesla is ...